Incordex Corp. financial data

Symbol
ICDX on OTC
Location
6 Rosemary Way, Nuneaton, United Kingdom
Fiscal year end
June 30
Latest financial report
10-Q - Q4 2024 - Aug 21, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 46.4 %
Debt-to-equity -1.26K % -323%
Return On Equity 240 %
Return On Assets -20.7 % -299%
Operating Margin -23.7 % +56.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.45M shares 0%
Common Stock, Shares, Outstanding 6.45M shares 0%
Entity Public Float 0 USD
Common Stock, Value, Issued 6.45K USD 0%
Weighted Average Number of Shares Outstanding, Diluted 6.45M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 13.5K USD -54.7%
General and Administrative Expense 36.3K USD +16.5%
Operating Income (Loss) -6.68K USD +13.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 5.36K USD +97.8%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -4.03K USD -225%
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.39K USD -43.6%
Assets, Current 1.72K USD -67.5%
Assets 1.72K USD -94.3%
Accounts Payable, Current 980 USD -93%
Liabilities, Current 980 USD -93%
Liabilities 980 USD -96.1%
Retained Earnings (Accumulated Deficit) -33.3K USD -13.8%
Stockholders' Equity Attributable to Parent 738 USD -84.5%
Liabilities and Equity 1.72K USD -94.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.76K USD -30.3%
Net Cash Provided by (Used in) Financing Activities 5K USD +25%
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 6.45M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.72K USD -41.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Depreciation 416 USD 0%
Additional Paid in Capital 27.6K USD 0%
Depreciation, Depletion and Amortization 1.75K USD +320%